{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:10:39Z","timestamp":1778749839431,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.prp.2025.156164","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:50:33Z","timestamp":1754751033000},"page":"156164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SCEL expression in tumor tissues: A potential prognostic biomarker for recurrent papillary thyroid carcinoma"],"prefix":"10.1016","volume":"274","author":[{"given":"Zexin","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingsheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5749-6560","authenticated-orcid":false,"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156164_bib1","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/816386","article-title":"Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma","volume":"2012","author":"Creach","year":"2012","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.prp.2025.156164_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100939","article-title":"Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy","volume":"68","author":"Liu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"5","key":"10.1016\/j.prp.2025.156164_bib3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1210\/clinem\/dgab836","article-title":"Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors","volume":"107","author":"Nieto","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.prp.2025.156164_bib4","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"},{"issue":"23","key":"10.1016\/j.prp.2025.156164_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237161","article-title":"Pathogenesis and management strategies in Radioiodine-Refractory differentiated thyroid cancer: from molecular mechanisms toward therapeutic approaches: a comprehensive review","volume":"13","author":"Voinea","year":"2024","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.prp.2025.156164_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102863","article-title":"Crosstalk between thyroid carcinoma and Tumor-Correlated immune cells in the tumor microenvironment","volume":"15","author":"Song","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-020-01757-x","article-title":"The molecular and gene\/miRNA expression profiles of radioiodine resistant papillary thyroid cancer","volume":"39","author":"Colombo","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2025.156164_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210024","article-title":"BRAF-AXL-PD-L1 signaling axis as a possible biological marker for RAI treatment in the thyroid cancer ATA intermediate risk category","volume":"24","author":"Pizzimenti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.156164_bib9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41422-020-0354-1","article-title":"Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis","volume":"30","author":"Wu","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2025.156164_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101196","article-title":"The immune response against cancer is modulated by stromal cell fibronectin","volume":"67","author":"Lubosch","year":"2025","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib11","article-title":"Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12929-023-00986-4","article-title":"SCEL regulates switches between pro-survival and apoptosis of the TNF-\u03b1\/TNFR1\/NF-\u03baB\/c-FLIP axis to control lung colonization of triple negative breast cancer","volume":"30","author":"Chan","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2025.156164_bib13","article-title":"Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer","volume":"245","author":"Liang","year":"2023","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s12672-025-02423-4","article-title":"Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-\u03b2\/Smad pathway","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2025.156164_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2025.05.024","article-title":"Advances in lung cancer basic and translational research in 2025 - overview and perspectives focusing on non-small cell lung cancer","author":"Mascaux","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82233-w","article-title":"Multiomics integration and machine learning reveal prognostic programmed cell death signatures in gastric cancer","volume":"14","author":"Bai","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2025.156164_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.path.2019.08.002","article-title":"Molecular alterations in thyroid carcinoma","volume":"12","author":"Haroon Al Rasheed","year":"2019","journal-title":"Surg. Pathol. Clin."},{"issue":"31","key":"10.1016\/j.prp.2025.156164_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci. Adv."},{"issue":"19","key":"10.1016\/j.prp.2025.156164_bib19","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-11-0720","article-title":"Proto-oncogene PBF\/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment","volume":"71","author":"Read","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mc.23268","article-title":"M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating \u03b2-catenin pathway in thyroid cancer","volume":"60","author":"Lv","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2025.156164_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/OTT.S294725","article-title":"Cancer-Associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid cancer","volume":"14","author":"Wen","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"4","key":"10.1016\/j.prp.2025.156164_bib22","first-page":"465","article-title":"Inhibition of human thyroid peroxidase gene expression by interleukin 1","volume":"121","author":"Ashizawa","year":"1989","journal-title":"Acta Endocrinol."},{"issue":"7","key":"10.1016\/j.prp.2025.156164_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/carcin\/bgt092","article-title":"A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma","volume":"34","author":"Plantinga","year":"2013","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.prp.2025.156164_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2025.156164_bib25","article-title":"Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.prp.2025.156164_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41422-019-0224-x","article-title":"Sustained type I interferon signaling as a mechanism of resistance to PD-1 blockade","volume":"29","author":"Jacquelot","year":"2019","journal-title":"Cell Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:26:04Z","timestamp":1778747164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"alternative-id":["S0344033825003577"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156164","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCEL expression in tumor tissues: A potential prognostic biomarker for recurrent papillary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156164"}}